The global tumor nutrition market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market can be attributed to the increasing number of cancer patients and rising awareness about the benefits of tumor nutrition among people.
Nutrition for stomach cancer is expected to account for the largest share in terms of type, followed by pancreatic cancer and early cancer patients. Nutrition for advanced cancer patients is expected to account for the largest share in terms of application, followed by early cancer patients and advanced cancer patients. North America is expected to account for the largest share in terms of region, followed by Europe and Asia Pacific respectively.
Some Of The Growth Factors Of This Market:
- Increasing prevalence of cancer and other chronic diseases will drive the growth of the Tumor Nutrition market.
- Rising awareness about the benefits of nutrition in cancer treatment will fuel the growth of this market.
- The increasing number of clinical trials for new drugs and therapies will create opportunities for Tumor Nutrition manufacturers.
- Increasing government funding for research on nutrition in cancer treatment.
Industry Growth Insights published a new data on “Tumor Nutrition Market”. The research report is titled “Tumor Nutrition Market research by Types (Nutrition for Stomach Cancer, Nutrition for Pancreatic Cancer, Other), By Applications (Early Cancer Patients, Advanced Cancer Patients), By Players/Companies Danone, Nestle, Abbott, Fresenius Kabi, Mead Johnson Company, Meiji Holdings, Hormel Foods Corporation, Global Health Products, Victus”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Tumor Nutrition Market Research Report
By Type
Nutrition for Stomach Cancer, Nutrition for Pancreatic Cancer, Other
By Application
Early Cancer Patients, Advanced Cancer Patients
By Companies
Danone, Nestle, Abbott, Fresenius Kabi, Mead Johnson Company, Meiji Holdings, Hormel Foods Corporation, Global Health Products, Victus
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
235
Number of Tables & Figures
165
Customization Available
Yes, the report can be customized as per your need.
Global Tumor Nutrition Market Report Segments:
The global Tumor Nutrition market is segmented on the basis of:
Types
Nutrition for Stomach Cancer, Nutrition for Pancreatic Cancer, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Early Cancer Patients, Advanced Cancer Patients
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Danone
- Nestle
- Abbott
- Fresenius Kabi
- Mead Johnson Company
- Meiji Holdings
- Hormel Foods Corporation
- Global Health Products
- Victus
Highlights of The Tumor Nutrition Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Nutrition for Stomach Cancer
- Nutrition for Pancreatic Cancer
- Other
- By Application:
- Early Cancer Patients
- Advanced Cancer Patients
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Tumor Nutrition Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Tumor nutrition refers to the specific needs of cancer cells. These needs may differ from those of healthy cells, and may include increased levels of certain nutrients or decreased levels of others. Cancer patients often require specialized diets to support their tumor growth and survival.
Some of the major players in the tumor nutrition market are Danone, Nestle, Abbott, Fresenius Kabi, Mead Johnson Company, Meiji Holdings, Hormel Foods Corporation, Global Health Products, Victus.
The tumor nutrition market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Tumor Nutrition Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Tumor Nutrition Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Tumor Nutrition Market - Supply Chain
4.5. Global Tumor Nutrition Market Forecast
4.5.1. Tumor Nutrition Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Tumor Nutrition Market Size (000 Units) and Y-o-Y Growth
4.5.3. Tumor Nutrition Market Absolute $ Opportunity
5. Global Tumor Nutrition Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Tumor Nutrition Market Size and Volume Forecast by Type
5.3.1. Nutrition for Stomach Cancer
5.3.2. Nutrition for Pancreatic Cancer
5.3.3. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Tumor Nutrition Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Tumor Nutrition Market Size and Volume Forecast by Application
6.3.1. Early Cancer Patients
6.3.2. Advanced Cancer Patients
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Tumor Nutrition Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Tumor Nutrition Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Tumor Nutrition Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Tumor Nutrition Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Tumor Nutrition Demand Share Forecast, 2019-2026
9. North America Tumor Nutrition Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Tumor Nutrition Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Tumor Nutrition Market Size and Volume Forecast by Application
9.4.1. Early Cancer Patients
9.4.2. Advanced Cancer Patients
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Tumor Nutrition Market Size and Volume Forecast by Type
9.7.1. Nutrition for Stomach Cancer
9.7.2. Nutrition for Pancreatic Cancer
9.7.3. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Tumor Nutrition Demand Share Forecast, 2019-2026
10. Latin America Tumor Nutrition Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Tumor Nutrition Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Tumor Nutrition Market Size and Volume Forecast by Application
10.4.1. Early Cancer Patients
10.4.2. Advanced Cancer Patients
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Tumor Nutrition Market Size and Volume Forecast by Type
10.7.1. Nutrition for Stomach Cancer
10.7.2. Nutrition for Pancreatic Cancer
10.7.3. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Tumor Nutrition Demand Share Forecast, 2019-2026
11. Europe Tumor Nutrition Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Tumor Nutrition Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Tumor Nutrition Market Size and Volume Forecast by Application
11.4.1. Early Cancer Patients
11.4.2. Advanced Cancer Patients
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Tumor Nutrition Market Size and Volume Forecast by Type
11.7.1. Nutrition for Stomach Cancer
11.7.2. Nutrition for Pancreatic Cancer
11.7.3. Other
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Tumor Nutrition Demand Share, 2019-2026
12. Asia Pacific Tumor Nutrition Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Tumor Nutrition Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Tumor Nutrition Market Size and Volume Forecast by Application
12.4.1. Early Cancer Patients
12.4.2. Advanced Cancer Patients
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Tumor Nutrition Market Size and Volume Forecast by Type
12.7.1. Nutrition for Stomach Cancer
12.7.2. Nutrition for Pancreatic Cancer
12.7.3. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Tumor Nutrition Demand Share, 2019-2026
13. Middle East & Africa Tumor Nutrition Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Tumor Nutrition Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Tumor Nutrition Market Size and Volume Forecast by Application
13.4.1. Early Cancer Patients
13.4.2. Advanced Cancer Patients
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Tumor Nutrition Market Size and Volume Forecast by Type
13.7.1. Nutrition for Stomach Cancer
13.7.2. Nutrition for Pancreatic Cancer
13.7.3. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Tumor Nutrition Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Tumor Nutrition Market: Market Share Analysis
14.2. Tumor Nutrition Distributors and Customers
14.3. Tumor Nutrition Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Danone
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Nestle
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Abbott
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Fresenius Kabi
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Mead Johnson Company
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Meiji Holdings
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Hormel Foods Corporation
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Global Health Products
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Victus
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
